3/4
05:57 am
cccc
C4 Therapeutics (CCCC) Loses -21.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner [Yahoo! Finance]
Low
Report
C4 Therapeutics (CCCC) Loses -21.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner [Yahoo! Finance]
2/27
07:08 pm
cccc
C4 Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights [Yahoo! Finance]
Low
Report
C4 Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights [Yahoo! Finance]
2/27
07:00 am
cccc
C4 Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
Low
Report
C4 Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
2/24
07:09 am
cccc
C4 Therapeutics to Participate in Upcoming March Investor Conferences [Yahoo! Finance]
Medium
Report
C4 Therapeutics to Participate in Upcoming March Investor Conferences [Yahoo! Finance]
2/24
07:00 am
cccc
C4 Therapeutics to Participate in Upcoming March Investor Conferences
Medium
Report
C4 Therapeutics to Participate in Upcoming March Investor Conferences
2/19
06:31 am
cccc
C4 Therapeutics, Inc. (NASDAQ: CCCC) was upgraded by analysts at UBS Group AG to a "hold" rating.
Low
Report
C4 Therapeutics, Inc. (NASDAQ: CCCC) was upgraded by analysts at UBS Group AG to a "hold" rating.